EcoR1 Capital LLC 13D and 13G filings for Centessa Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:43 pm Sale |
2024-09-30 | 13G | Centessa Pharmaceuticals plc CNTA |
EcoR1 Capital LLC | 3,223,851 2.900% |
-2,394,928 (-42.62%) |
Filing |
| 2024-02-14 5:37 pm Purchase |
2023-12-31 | 13G | Centessa Pharmaceuticals plc CNTA |
EcoR1 Capital LLC | 5,618,779 5.800% |
386,500 (+7.39%) |
Filing |
| 2022-11-23 12:28 pm Purchase |
2022-11-14 | 13G | Centessa Pharmaceuticals plc CNTA |
EcoR1 Capital LLC | 5,232,279 5.500% |
5,232,279 (New Position) |
Filing |